« Back to Record
Citation APA

Piccart-Gebhart, M., Di Leo, A., Beauduin, M., Vindevoghel, A., Michel, J., Focan, C., Tagnon, A., Ries, F., Gobert, P., Finet, C., Closon-Dejardin, M. T., Dufrane, J. P., Kerger, J., Liebens, F., Beauvois, S., Bartholomeus, S., Dolci, S., Lobelle, J. P., Paesmans, M., & Nogaret, J.-M. (2001). Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. Journal of clinical oncology, 19(12), 3103-3110.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55829

Piccart-Gebhart, M., Di Leo, A., Beauduin, M., Vindevoghel, A., Michel, J., Focan, C., Tagnon, A., Ries, F., Gobert, P., Finet, C., Closon-Dejardin, M. T., Dufrane, J. P., Kerger, J., Liebens, F., Beauvois, S., Bartholomeus, S., Dolci, S., Lobelle, J. P., Paesmans, M., & Nogaret, J.-M. (2001). Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. Journal of clinical oncology, 19(12), 3103-3110.